[HTML][HTML] HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and …

RK Gupta, J Gregson, N Parkin… - The Lancet infectious …, 2018 - thelancet.com
Background Pretreatment drug resistance in people initiating or re-initiating antiretroviral
therapy (ART) containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) might …

Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor–containing …

S Bertagnolio, L Hermans, MR Jordan… - The Journal of …, 2021 - academic.oup.com
Background Increased access to antiretroviral therapy (ART) has resulted in rising levels of
pretreatment human immunodeficiency virus drug resistance (PDR). This is the first …

[HTML][HTML] Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

MJ Siedner, MA Moorhouse, B Simmons… - Nature …, 2020 - nature.com
Little is known about the impact of pretreatment drug resistance (PDR) on the efficacy of
second generation integrase inhibitors. We sequenced pretreatment plasma specimens …

[HTML][HTML] Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001–2017)

L Zuo, K Liu, H Liu, Y Hu, Z Zhang, J Qin, Q Xu… - …, 2020 - thelancet.com
Background The emergence and spread of HIV-1 drug resistance may compromise HIV
control globally. In response to HIV/AIDS epidemic, China launched national HIV/AIDS …

[HTML][HTML] Next-generation sequencing for HIV drug resistance testing: laboratory, clinical, and implementation considerations

S Ávila-Ríos, N Parkin, R Swanstrom, R Paredes… - Viruses, 2020 - mdpi.com
Higher accessibility and decreasing costs of next generation sequencing (NGS), availability
of commercial kits, and development of dedicated analysis pipelines, have allowed an …

[HTML][HTML] Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

ER Lee, N Parkin, C Jennings, CJ Brumme, E Enns… - Scientific Reports, 2020 - nature.com
Next generation sequencing (NGS) is a trending new standard for genotypic HIV-1 drug
resistance (HIVDR) testing. Many NGS HIVDR data analysis pipelines have been …

Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing

PL Tzou, P Ariyaratne, V Varghese, C Lee… - Journal of clinical …, 2018 - Am Soc Microbiol
The ability of next-generation sequencing (NGS) technologies to detect low frequency HIV-1
drug resistance mutations (DRMs) not detected by dideoxynucleotide Sanger sequencing …

[HTML][HTML] The impact of HIV-1 drug escape on the global treatment landscape

DA Collier, C Monit, RK Gupta - Cell host & microbe, 2019 - cell.com
The rising prevalence of HIV drug resistance (HIVDR) could threaten gains made in
combating the HIV epidemic and compromise the 90-90-90 target proposed by United …

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - academic.oup.com
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

[HTML][HTML] Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping

NT Parkin, S Avila-Rios, DF Bibby, CJ Brumme… - Viruses, 2020 - mdpi.com
Next-generation sequencing (NGS) is increasingly used for HIV-1 drug resistance
genotyping. NGS methods have the potential for a more sensitive detection of low …